Eva Lundqvist

Director Early Clinical Development, TFS Trial Form Support International

Eva Lundqvist started her career as an Engineer and Scientist within Molecular Genetics at Pharmacia Biotech in Uppsala and later worked as an international Product specialist within the same company. She also worked within Clinical Drug Development as a CRA and Clinical Team Leader at Pharmacia &Upjohn in Stockholm with a focus on oncology studies phase I-III. In 2000, Eva joined TFS as a Clinical Research Manager and in 2001 she became the Clinical Operations Manager of the Stockholm office. In 2004, she was appointed as Country Manager for the TFS affiliate in Manchester, UK and was responsible for all operational activities in the UK. Since 2006 Eva holds the position as Director Early Clinical Development and manages the TFS Phase I Unit located at Karolinska University Hospital, Stockholm, Sweden. Eva is a member of SwedenBio and the Swedish Pharmaceutical Society. Eva holds a Master of Science in Medical Science from Uppsala University, and has a Medical Licentiate postgraduate degree in Pharmacogenetics from the Karolinska Institute, Stockholm.